MedTrace Logo

Duration of Doxycycline Treatment in MEM Patients

NCT03337932 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-04-29

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.

Conditions

  • Erythema Chronicum Migrans

Interventions

DRUG

Doxycycline 100 milligram Oral Tablet bid, 7 days

Patients will receive doxycycline for 7 days.

DRUG

Doxycycline 100 milligram Oral Tablet bid, 14 days

Patients will receive doxycycline for 14 days.

DRUG

Controls without a history of lyme disease.

No intervention.

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Daša Stupica, MD PhD · University Medical Centre Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03337932 on ClinicalTrials.gov